Ruth Oren Hommonai
Algemeen Directeur bij INTER GAMMA INVESTMENT COMPANY LTD
Actieve functies van Ruth Oren Hommonai
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Algemeen Directeur | 01-01-2014 | - |
| Directeur/Bestuurslid | 27-08-2009 | - | |
| Algemeen Adviseur | - | - | |
| Bedrijfssecretaris | - | - |
Loopbaan van Ruth Oren Hommonai
Eerdere bekende functies van Ruth Oren Hommonai
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Algemeen Adviseur | - | - |
Opleiding van Ruth Oren Hommonai
| Tel-Aviv University | Graduate Degree |
| The Interdisciplinary Center Herzliya | Masters Business Admin |
Statistieken
Internationaal
| Israël | 5 |
Operationeel
| General Counsel | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
- Beurs
- Insiders
- Ruth Oren Hommonai
- Ervaring
